TMCI
Treace Medical·NASDAQ
--
--(--)
--
--(--)
4.06 / 10
Netural
Analyst consensus is neutral, with two analysts issuing ratings and no strong buy or sell bias. Fund flow data show a good overall score of 7.68, yet the trend is negative across block, medium, large, and extra-large flows, tempered only by positive small-movement inflows. This mixed profile suggests limited institutional conviction and ongoing selling pressure.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-18
InstitutionTruist Securities
Times predicted7
Historical Win Rate14.3%
What is the market sentiment for TMCI?
- TMCI holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.06/10 (Netural).
